Clinical trial
NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia
NCT00476541 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00476541 |
|---|---|
| Title | NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia |
| Official title | NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia |
| Lead sponsor | University of Aarhus, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | Gemtuzumab ozogamicin |
| Enrollment | 250 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | May 22, 2007 |
| Last update posted | May 13, 2016 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: